OK1 — OKYO Pharma Cashflow Statement
0.000.00%
Last trade - 00:00- €0.56m
- -€0.17m
Annual cashflow statement for OKYO Pharma, fiscal year end - March 31st, GBP millions except per share, conversion factor applied.
2018 March 31st | 2019 March 31st | C2020 March 31st | 2021 March 31st | 2022 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -20.2 | -3.76 | -1.27 | -3.02 | -4.55 |
| Depreciation | |||||
| Non-Cash Items | 19 | 2.1 | 0.178 | 0.903 | 1.32 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.025 | 0.136 | 0.13 | 0.859 | -0.75 |
| Change in Accounts Receivable | |||||
| Change in Accounts Payable | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Taxes Payable | |||||
| Cash from Operating Activities | -1.14 | -1.53 | -0.961 | -1.24 | -3.98 |
| Capital Expenditures | 0 | -0.001 | 0 | -0.005 | -0.001 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | — | -0.104 | -0.009 | 0 |
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 0 | -0.001 | -0.104 | -0.014 | -0.001 |
| Financing Cash Flow Items | — | — | 0 | 0.001 | 0 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | — | — | 0.774 | 6.06 | 1.05 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -1.14 | -1.53 | -0.291 | 4.8 | -2.94 |